Ads
related to: jardiance- How RYBELSUS® Works
Learn More About How RYBELSUS®
Works At The Patient Website.
- What To Expect
Visit The Patient Site To Learn
More About RYBELSUS®.
- Sign Up For Savings
Eligible Patients May Save On
Their RYBELSUS® Prescriptions.
- Prescribing Information
View Prescribing Information For
A Potential Treatment Option.
- FAQs
Explore Frequently Asked Questions
& Learn More Today!
- Patient Stories
Discover Real Patient's Stories
With Using RYBELSUS®.
- How RYBELSUS® Works
Search results
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease
Zacks via Yahoo Finance· 8 months agoEli Lilly LLY announced that the FDA has expanded the label of its diabetes drug, Jardiance...
Lilly, Boehringer say Jardiance slows kidney disease progression in trial
Reuters via Yahoo News· 2 years agoBoehringer Ingelheim and Eli Lilly said their diabetes drug Jardiance was shown to slow the...
Lilly-Boehringer Partnered Jardiance Slows Kidney Disease Progression, Data Shows
Benzinga via Yahoo Finance· 2 years agoBoehringer Ingelheim and Eli Lilly And Co (NYSE: LLY) said their diabetes drug Jardiance showed to...
FDA Approves New Class of Oral Medicines for Children with Type 2 Diabetes
Benzinga via Yahoo Finance· 11 months agoOn Tuesday, the FDA approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...
Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
Zacks via Yahoo Finance· 7 months agoThis week, the European Commission granted marketing approval to AbbVie’s ABBV Tepkinly...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo Finance· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Eli Lilly (LLY) Q2 Earnings Beat, Mounjaro Powers Sales Growth
Zacks via Yahoo Finance· 9 months agoEli Lilly and Company LLY reported second-quarter 2023 adjusted earnings per share of $2.11, which...
4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade
Motley Fool via Yahoo Finance· 3 months agoEli Lilly (NYSE: LLY) had a very good year in 2023. Revenue jumped 20% and its stock skyrocketed...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 weeks agoEli Lilly and Company LLY will report first-quarter 2024 results on Apr 30, before market open. The...
Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 1 year agoWe expect Eli Lilly & Company LLY to beat expectations when it reports first-quarter 2023 results on...
